TrialPanorama/TrialPanorama-database huggingface dataset:
Study NCT03029611 — Predictive Biomarker (PRD): IGFBP2 mRNA
Genes: IGFBP2; BP2; IBP2
Study NCT04553783 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT04553783 — Pharmacodynamic Biomarker (PDY): Serum phosphate
Study NCT03102684 — Predictive Biomarker (PRD): Exhaled nitric oxide
Study NCT00683943 — Predictive Biomarker (PRD): ATXN1 mRNA
Genes: ATXN1; ATX1; SCA1
Study NCT01723306 — Monitoring Biomarker (MOI): Carcinoembryonic antigen CEA
Genes: CEACAM5; CEA
Study NCT01723306 — Safety Biomarker (SAF): Interleukin 2
Genes: IL2
Study NCT00264277 — Safety Biomarker (SAF); Monitoring Biomarker (MOI): D-dimer
Study NCT01774942 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT00644267 — Surrogate Endpoint (SUR): Blood pressure
Study NCT02198144 — Surrogate Endpoint (SUR): Blood pressure
Study NCT00094783 — Surrogate Endpoint (SUR): Blood pressure
Study NCT02187393 — Predictive Biomarker (PRD): DSP mRNA
Genes: DSP
Study NCT02187393 — Predictive Biomarker (PRD): MUC5B mRNA
Genes: MUC5B; MUC5
Study NCT00336362 — Safety Biomarker (SAF): Granulocyte-macrophage colony-stimulating factor
Genes: CSF2; GMCSF
Study NCT02532452 — Predictive Biomarker (PRD); Safety Biomarker (SAF): White blood cell
Study NCT02500550 — Predictive Biomarker (PRD): CD34 mRNA
Genes: CD34
Study NCT01047410 — Surrogate Endpoint (SUR): Blood pressure
Study NCT00138840 — Safety Biomarker (SAF): Interleukin 12
Study NCT03376828 — Surrogate Endpoint (SUR): Blood pressure
Study NCT04107220 — Safety Biomarker (SAF): B-type natriuretic peptide
Genes: NPPB
Study NCT02720861 — Predictive Biomarker (PRD): RNF213 mRNA
Genes: RNF213; ALO17; C17orf27; KIAA1554; KIAA1618; MYSTR
Study NCT04953585 — Safety Biomarker (SAF); Monitoring Biomarker (MOI): D-dimer
Study NCT02290145 — Predictive Biomarker (PRD): CCND1 mRNA
Genes: CCND1; BCL1; PRAD1
Study NCT02290145 — Predictive Biomarker (PRD): CCND1
Genes: U21B31
Study NCT04261010 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT04181996 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT04181996 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study NCT00201851 — Predictive Biomarker (PRD): Hormone receptor
Study NCT04351100 — Safety Biomarker (SAF): Interleukin 1
Study NCT04351100 — Safety Biomarker (SAF): Interleukin 1 alpha
Genes: IL1A; IL1F1
Study NCT01025609 — Surrogate Endpoint (SUR): Blood pressure
Study NCT03210259 — Surrogate Endpoint (SUR): Neutralizing antibody
Study NCT04334941 — Predictive Biomarker (PRD): SLFN11 mRNA
Genes: SLFN11
Study NCT02801591 — Predictive Biomarker (PRD): POR mRNA
Genes: POR; CYPOR
Study NCT02790489 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT02790489 — Surrogate Endpoint (SUR): Blood pressure
Study NCT02887612 — Monitoring Biomarker (MOI): Circulating tumor DNA
Study NCT02887612 — Monitoring Biomarker (MOI): Cell-free DNA
Study NCT04351191 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study NCT04766294 — Pharmacodynamic Biomarker (PDY): Matrix metalloproteinase 9
Genes: MMP9; CLG4B
Study NCT03726736 — Predictive Biomarker (PRD): PDGFRB mRNA
Genes: PDGFRB; PDGFR; PDGFR1
Study NCT03726736 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT02465060 — Predictive Biomarker (PRD): GCNT2 mRNA
Genes: GCNT2; GCNT5; II; NACGT1
Study NCT03328819 — Predictive Biomarker (PRD): BPI mRNA
Genes: BPI
Study NCT03328819 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT03328819 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study NCT03328819 — Safety Biomarker (SAF): Interleukin 12
Study NCT05995821 — Monitoring Biomarker (MOI): Circulating tumor DNA
Study NCT04241029 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT00692939 — Predictive Biomarker (PRD): CD34 mRNA
Genes: CD34
Study NCT01702688 — Predictive Biomarker (PRD): KDM1A mRNA
Genes: KDM1A; AOF2; KDM1; KIAA0601; LSD1
Study NCT01702688 — Surrogate Endpoint (SUR): Blood pressure
Study NCT03731793 — Predictive Biomarker (PRD): CS mRNA
Genes: CS
Study NCT03731793 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT01472276 — Surrogate Endpoint (SUR): Blood pressure
Study NCT00723697 — Predictive Biomarker (PRD): FLCN mRNA
Genes: FLCN; BHD
Study NCT00784758 — Surrogate Endpoint (SUR): Forced vital capacity
Study NCT00730093 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Monitoring Biomarker (MOI): Vitamin B12
Study NCT04800445 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT01548950 — Predictive Biomarker (PRD): PAH mRNA
Genes: PAH
Study NCT01548950 — Surrogate Endpoint (SUR): Pulmonary vascular resistance
Study NCT01504828 — Pharmacodynamic Biomarker (PDY): Angiotensin-converting enzyme
Genes: ACE; DCP; DCP1
Study NCT00468923 — Surrogate Endpoint (SUR): Blood pressure
Study NCT02351128 — Predictive Biomarker (PRD): MCC mRNA
Genes: MCC
Study NCT00270699 — Surrogate Endpoint (SUR): Neutralizing antibody
Study NCT02308371 — Surrogate Endpoint (SUR): Blood pressure
Study NCT02620163 — Surrogate Endpoint (SUR): Blood pressure
Study NCT00935064 — Pharmacodynamic Biomarker (PDY): Angiotensinogenase renin
Genes: REN
Study NCT04014335 — Predictive Biomarker (PRD): CFB mRNA
Genes: CFB; BF; BFD
Study NCT01650805 — Predictive Biomarker (PRD): BCR mRNA
Genes: BCR; BCR1; D22S11
Study NCT01650805 — Pharmacodynamic Biomarker (PDY): Tyrosine-protein kinase ABL1
Genes: ABL1; ABL; JTK7
Study NCT02053805 — Predictive Biomarker (PRD): BRCA1 mRNA
Genes: BRCA1; RNF53
Study NCT02053805 — Predictive Biomarker (PRD): BRCA2 mRNA
Genes: BRCA2; FACD; FANCD1
Study NCT00000889 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study NCT00000889 — Safety Biomarker (SAF): Interleukin 2
Genes: IL2
Study NCT01907685 — Predictive Biomarker (PRD): MXD1 mRNA
Genes: MXD1; MAD
Study NCT01507831 — Predictive Biomarker (PRD): PCSK9 mRNA
Genes: PCSK9; NARC1; PSEC0052
Study NCT01507831 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study NCT02860507 — Pharmacodynamic Biomarker (PDY): Transmembrane glycoprotein NMB
Genes: GPNMB; HGFIN; NMB; UNQ1725/PRO9925
Study NCT01623024 — Predictive Biomarker (PRD): VDR mRNA
Genes: VDR; NR1I1
Study NCT03633331 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT03633331 — Predictive Biomarker (PRD): Estrogen receptor
Genes: ESR1; ESR; NR3A1
Study NCT01009294 — Predictive Biomarker (PRD): DMD mRNA
Genes: DMD
Study NCT01009294 — Predictive Biomarker (PRD): DMD
Genes: BMD; DXS142; DXS164; DXS206; DXS230; DXS239; DXS268; DXS269; DXS270; DXS272
Study NCT04623671 — Predictive Biomarker (PRD): CAP1 mRNA
Genes: CAP1; CAP
Study NCT03793166 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study NCT03259737 — Surrogate Endpoint (SUR): Blood pressure
Study NCT01556178 — Safety Biomarker (SAF): Granulocyte-macrophage colony-stimulating factor
Genes: CSF2; GMCSF
Study NCT01881529 — Predictive Biomarker (PRD): LOXL2 mRNA
Genes: LOXL2
Study NCT04011085 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT03622333 — Predictive Biomarker (PRD): IPMK mRNA
Genes: IPMK; IMPK
Study NCT03349177 — Surrogate Endpoint (SUR): Pathological complete response
Study NCT01402557 — Surrogate Endpoint (SUR): Blood pressure
Study NCT04588844 — Predictive Biomarker (PRD): Hormone receptor
Study NCT02642042 — Predictive Biomarker (PRD): KRAS mRNA
Genes: KRAS; KRAS2; RASK2
Study NCT03288207 — Surrogate Endpoint (SUR): Blood pressure
Study NCT03738761 — Surrogate Endpoint (SUR): Blood pressure
Study NCT00602446 — Predictive Biomarker (PRD): Liver iron
Study NCT02455973 — Surrogate Endpoint (SUR): Blood pressure
Study NCT01422746 — Predictive Biomarker (PRD): POMC
Genes: MSH; POC; CLIP; ACTH; NPP; LPH
Study NCT00501722 — Surrogate Endpoint (SUR): Serum sodium
Study NCT01260272 — Surrogate Endpoint (SUR): Blood pressure
Study NCT01260272 — Pharmacodynamic Biomarker (PDY): High density lipoprotein cholesterol
Study NCT01146561 — Predictive Biomarker (PRD): Nerve growth factor
Genes: NGF; NGFB
Study NCT01916785 — Predictive Biomarker (PRD): BCR mRNA
Genes: BCR; BCR1; D22S11
Study NCT01916785 — Pharmacodynamic Biomarker (PDY): Tyrosine-protein kinase ABL1
Genes: ABL1; ABL; JTK7
Study NCT02364466 — Safety Biomarker (SAF): Granulocyte-macrophage colony-stimulating factor
Genes: CSF2; GMCSF
Study NCT03905538 — Predictive Biomarker (PRD): FLT1 mRNA
Genes: FLT1; FLT; FRT; VEGFR1
Study NCT01513785 — Safety Biomarker (SAF): Cytochrome P450 2C19
Genes: CYP2C19
Study NCT01944228 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT04391556 — Predictive Biomarker (PRD): Glutamate carboxypeptidase II
Genes: FOLH1; FOLH; NAALAD1; PSM; PSMA; GIG27
Study NCT04391556 — Predictive Biomarker (PRD): NPEPPS mRNA
Genes: NPEPPS; PSA
Study NCT01085227 — Pharmacodynamic Biomarker (PDY): Leucine-rich repeat kinase 2
Genes: LRRK2; PARK8
Study NCT01085227 — Pharmacodynamic Biomarker (PDY): Synuclein alpha
Genes: SNCA; NACP; PARK1
Study NCT00411047 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT00411047 — Monitoring Biomarker (MOI): Epidermal growth factor
Genes: EGF
Study NCT01403142 — Predictive Biomarker (PRD); Safety Biomarker (SAF): CAV1 mRNA
Genes: CAV1; CAV
Study NCT03769103 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT03769103 — Monitoring Biomarker (MOI): Epidermal growth factor
Genes: EGF
Study NCT01074021 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT01074021 — Monitoring Biomarker (MOI): Epidermal growth factor
Genes: EGF
Study NCT01398592 — Pharmacodynamic Biomarker (PDY): Dipeptidyl peptidase 4
Genes: DPP4; ADCP2; CD26
Study NCT02783781 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT02783781 — Safety Biomarker (SAF): B-type natriuretic peptide
Genes: NPPB
Study NCT02783781 — Surrogate Endpoint (SUR): Serum creatinine
Study NCT03425383 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT00005437 — Surrogate Endpoint (SUR): Blood pressure
Study NCT01555281 — Predictive Biomarker (PRD); Safety Biomarker (SAF): PIK3CA
Genes: PI3K
Study NCT01900860 — Surrogate Endpoint (SUR): Bone mineral density
Study NCT00883753 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT01699217 — Predictive Biomarker (PRD): BCR mRNA
Genes: BCR; BCR1; D22S11
Study NCT01699217 — Pharmacodynamic Biomarker (PDY): Tyrosine-protein kinase ABL1
Genes: ABL1; ABL; JTK7
Study NCT00756847 — Predictive Biomarker (PRD): PI3 mRNA
Genes: PI3; WAP3; WFDC14
Study NCT00756847 — Predictive Biomarker (PRD); Safety Biomarker (SAF): PIK3CA
Genes: PI3K
Study NCT00003789 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT03808311 — Surrogate Endpoint (SUR): Blood pressure
Study NCT02217059 — Surrogate Endpoint (SUR): Blood pressure
Study NCT01714856 — Surrogate Endpoint (SUR): Blood pressure
Study NCT01753089 — Safety Biomarker (SAF): Granulocyte-macrophage colony-stimulating factor
Genes: CSF2; GMCSF
Study NCT04597580 — Predictive Biomarker (PRD): TK1 mRNA
Genes: TK1
Study NCT04597580 — Predictive Biomarker (PRD): CDK4 mRNA
Genes: CDK4
Study NCT04496089 — Predictive Biomarker (PRD): Carbonic anhydrase IX
Genes: CA9; G250; MN
Study NCT04443881 — Safety Biomarker (SAF): Interleukin 1
Study NCT04856761 — Predictive Biomarker (PRD): BTC mRNA
Genes: BTC
Study NCT03682029 — Predictive Biomarker (PRD): TET2 mRNA
Genes: TET2; KIAA1546; Nbla00191
Study NCT04630054 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study NCT04756544 — Surrogate Endpoint (SUR): Blood pressure
Study NCT04756544 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT00794573 — Surrogate Endpoint (SUR): Exhaled carbon monoxide
Study NCT01360125 — Predictive Biomarker (PRD): CD55 mRNA
Genes: CD55; CR; DAF
Study NCT01360125 — Predictive Biomarker (PRD): CCR1 mRNA
Genes: CCR1; CMKBR1; CMKR1; SCYAR1
Study NCT04106219 — Predictive Biomarker (PRD): Aurora kinase A
Genes: AURKA; AIK; AIRK1; ARK1; AURA; AYK1; BTAK; IAK1; STK15; STK6
Study NCT02600806 — Monitoring Biomarker (MOI): Procalcitonin
Study NCT00845676 — Predictive Biomarker (PRD): IFNL3 mRNA
Genes: IFNL3; IL28B; IL28C; ZCYTO22
Study NCT02291848 — Predictive Biomarker (PRD): MAGEA4 mRNA
Genes: MAGEA4; MAGE4
Study NCT02291848 — Predictive Biomarker (PRD): PRAME mRNA
Genes: PRAME; MAPE; OIP4
Study NCT04517838 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT02420938 — Predictive Biomarker (PRD): TNFRSF9 mRNA
Genes: TNFRSF9; CD137; ILA
Study NCT01217281 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT01217281 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT01217281 — Safety Biomarker (SAF): Cystatin C
Genes: CST3
Study NCT04355611 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study NCT03256513 — Surrogate Endpoint (SUR): Blood pressure
Study NCT02893852 — Predictive Biomarker (PRD): DCD mRNA
Genes: DCD; AIDD; DSEP
Study NCT00894985 — Predictive Biomarker (PRD): TTPA mRNA
Genes: TTPA; TPP1
Study NCT01407328 — Surrogate Endpoint (SUR): Forced vital capacity
Study NCT00586391 — Predictive Biomarker (PRD): B-lymphocyte surface antigen B4
Genes: CD19
Study NCT00586391 — Predictive Biomarker (PRD): CD28 mRNA
Genes: CD28
Study NCT01861197 — Predictive Biomarker (PRD): FGFR1 mRNA
Genes: FGFR1; BFGFR; CEK; FGFBR; FLG; FLT2; HBGFR
Study NCT02707432 — Surrogate Endpoint (SUR): Blood pressure
Study NCT02019979 — Pharmacodynamic Biomarker (PDY): 5'-AMP-activated protein kinase subunit beta-1
Genes: PRKAB1; AMPK
Study NCT02019979 — Predictive Biomarker (PRD): MTOR mRNA
Genes: MTOR; FRAP; FRAP1; FRAP2; RAFT1; RAPT1
Study NCT03047538 — Surrogate Endpoint (SUR): Blood pressure
Study NCT02061085 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT03643107 — Predictive Biomarker (PRD): AR mRNA
Genes: AR; DHTR; NR3C4
Study NCT01471327 — Predictive Biomarker (PRD): Interleukin 5
Genes: IL5
Study NCT02166450 — Surrogate Endpoint (SUR): Blood pressure
Study NCT04215094 — Monitoring Biomarker (MOI): Procalcitonin
Study NCT04215094 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT04215094 — Predictive Biomarker (PRD); Safety Biomarker (SAF): White blood cell
Study NCT04972383 — Safety Biomarker (SAF): Hyaluronic acid
Study NCT02835599 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT02617134 — Predictive Biomarker (PRD); Monitoring Biomarker (MOI): Mucin-1
Genes: MUC1; PUM
Study NCT02626338 — Predictive Biomarker (PRD): FLT3 mRNA
Genes: FLT3; CD135; FLK2; STK1
Study NCT02314533 — Surrogate Endpoint (SUR): Serum creatinine
Study NCT04432454 — Predictive Biomarker (PRD): Estrogen receptor
Genes: ESR1; ESR; NR3A1
Study NCT01065363 — Monitoring Biomarker (MOI): HBV DNA
Study NCT03335943 — Predictive Biomarker (PRD): CDA mRNA
Genes: CDA; CDD
Study NCT03519113 — Monitoring Biomarker (MOI): HBV DNA
Study NCT02343380 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Free fatty acids
Study NCT02123329 — Surrogate Endpoint (SUR): Exhaled carbon monoxide
Study NCT01259674 — Predictive Biomarker (PRD): ABO mRNA
Genes: ABO
Study NCT00753636 — Surrogate Endpoint (SUR): Blood pressure
Study NCT04062955 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT03953781 — Surrogate Endpoint (SUR): Sperm parameters
Study NCT04503980 — Predictive Biomarker (PRD): MSLN mRNA
Genes: MSLN; MPF
Study NCT03701295 — Predictive Biomarker (PRD): HOXA9 mRNA
Genes: HOXA9; HOX1G
Study NCT03341494 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT03341494 — Monitoring Biomarker (MOI): Epidermal growth factor
Genes: EGF
Study NCT02484261 — Predictive Biomarker (PRD): CD34 mRNA
Genes: CD34
Study NCT00738738 — Predictive Biomarker (PRD): GAD1 mRNA
Genes: GAD1; GAD; GAD67
Study NCT02273973 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT02273973 — Predictive Biomarker (PRD): PIK3CA mRNA
Genes: PIK3CA
Study NCT02273973 — Predictive Biomarker (PRD): Estrogen receptor
Genes: ESR1; ESR; NR3A1
Study NCT02273973 — Monitoring Biomarker (MOI): Epidermal growth factor
Genes: EGF
Study NCT00771303 — Safety Biomarker (SAF); Monitoring Biomarker (MOI): D-dimer
Study NCT01938183 — Surrogate Endpoint (SUR): Probing pocket depth
Study NCT00817414 — Predictive Biomarker (PRD): POMC
Genes: MSH; POC; CLIP; ACTH; NPP; LPH
Study NCT02301962 — Predictive Biomarker (PRD): KRAS mRNA
Genes: KRAS; KRAS2; RASK2
Study NCT02301962 — Predictive Biomarker (PRD): NRAS mRNA
Genes: NRAS; HRAS1
Study NCT00219440 — Predictive Biomarker (PRD): PPARA mRNA
Genes: PPARA; NR1C1; PPAR
Study NCT02648984 — Predictive Biomarker (PRD): PAH mRNA
Genes: PAH
Study NCT02648984 — Predictive Biomarker (PRD): PVR mRNA
Genes: PVR; PVS
Study NCT02648984 — Surrogate Endpoint (SUR): Pulmonary vascular resistance
Study NCT00206557 — Predictive Biomarker (PRD): Estrogen receptor
Genes: ESR1; ESR; NR3A1
Study NCT01576367 — Predictive Biomarker (PRD): CAPS mRNA
Genes: CAPS
Study NCT00455533 — Predictive Biomarker (PRD): Multidrug resistance protein 1
Genes: ABCB1; MDR1; PGY1
Study NCT00455533 — Predictive Biomarker (PRD): Estrogen receptor
Genes: ESR1; ESR; NR3A1
Study NCT05157074 — Pharmacodynamic Biomarker (PDY): Huntingtin
Genes: HTT; HD; IT15
Study NCT02817854 — Monitoring Biomarker (MOI): Procalcitonin
Study NCT02817854 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT01625845 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT01625845 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT04545307 — Predictive Biomarker (PRD): MSC mRNA
Genes: MSC; ABF1; BHLHA22
Study NCT02525029 — Monitoring Biomarker (MOI): Epidermal growth factor
Genes: EGF
Study NCT00379171 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT01378910 — Predictive Biomarker (PRD): CCR5 mRNA
Genes: CCR5; CMKBR5
Study NCT04556864 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study NCT04823871 — Predictive Biomarker (PRD): MAF mRNA
Genes: MAF
Study NCT03982667 — Monitoring Biomarker (MOI): Procalcitonin
Study NCT02069093 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT02069093 — Predictive Biomarker (PRD): Hormone receptor
Study NCT00401427 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT04686812 — Surrogate Endpoint (SUR): Blood pressure
Study NCT03038022 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study NCT01653574 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT00145756 — Surrogate Endpoint (SUR): Blood pressure
Study NCT01243840 — Surrogate Endpoint (SUR): Blood pressure
Study NCT02360657 — Pharmacodynamic Biomarker (PDY): Amyloid beta peptide (1-40)
Genes: APP; A4; AD1
Study NCT04525326 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT00011830 — Safety Biomarker (SAF): Granulocyte-macrophage colony-stimulating factor
Genes: CSF2; GMCSF
Study NCT02309632 — Predictive Biomarker (PRD): PC mRNA
Genes: PC
Study NCT00263081 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study NCT00263081 — Pharmacodynamic Biomarker (PDY): High density lipoprotein cholesterol
Study NCT04146753 — Surrogate Endpoint (SUR): Blood pressure
Study NCT02791438 — Surrogate Endpoint (SUR): Blood pressure
Study NCT01245816 — Predictive Biomarker (PRD): FAP mRNA
Genes: FAP
Study NCT04492410 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study NCT03128463 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study NCT03128463 — Predictive Biomarker (PRD): AMD1 mRNA
Genes: AMD1; AMD
Study NCT00540215 — Surrogate Endpoint (SUR): Blood pressure
Study NCT04651400 — Safety Biomarker (SAF): Antithrombin-III
Genes: SERPINC1; AT3; PRO0309
Study NCT03675191 — Surrogate Endpoint (SUR): Blood pressure
Study NCT01183741 — Surrogate Endpoint (SUR): Blood pressure
Study NCT03167255 — Predictive Biomarker (PRD): DMD mRNA
Genes: DMD
Study NCT02566798 — Safety Biomarker (SAF): Hyaluronic acid
Study NCT00758134 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT04148183 — Surrogate Endpoint (SUR): Blood pressure
Study NCT01840683 — Predictive Biomarker (PRD): AMD1 mRNA
Genes: AMD1; AMD
Study NCT03586661 — Predictive Biomarker (PRD); Safety Biomarker (SAF): PIK3CA
Genes: PI3K
Study NCT02609776 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT03767244 — Surrogate Endpoint (SUR): Pathological complete response
Study NCT04175600 — Predictive Biomarker (PRD): PAH mRNA
Genes: PAH
Study NCT03717740 — Surrogate Endpoint (SUR): Blood pressure
Study NCT04474912 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Interleukin 17
Genes: IL17A; CTLA8; IL17
Study NCT00677924 — Monitoring Biomarker (MOI): Epidermal growth factor
Genes: EGF